CD4 and neoplasm: HLA-DR positive cells in particular seem to be crucial for immunological tumor control, as HLA-DR loss is linked to tumor escape from immunosurveillance [26], and higher numbers of activated HLA-DR + CD4 + cells were associated with a better prognosis in B-NHL patients [27].